SAVSU Technologies to Supply evo® Cold Chain Technologies to AveXis

Temperature Sensitive Gene Therapy Protected by Cloud-Connected Smart Shipper and Cloud App for Real Time Distribution Visibility and Management

On November 5, 2018, BioLife’s JV partner  SAVSU Technologies, a leading developer and supplier of precision cloud-connected thermal shipping containers and the most advanced cold chain visibility platform, announced that it is supplying its evo Smart Shipper and to AveXis, a gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases.

Bruce McCormick, SAVSU President, commented, “We are very pleased to partner with AveXis to supply our best in class evo Smart Shipper and cloud app. We look forward to additional announcements related to adoption of our innovative cold chain technologies by cell and gene therapy companies.”

Privately held SAVSU Technologies is driving improved cold chain management of time and temperature cell and gene therapies through innovation and leveraged relationships with the leading specialty couriers serving the regenerative medicine market.  BioLife Solutions (NASDAQ:BLFS), the leading supplier of biopreservation tools for regenerative medicine, holds a 44% equity ownership position in SAVSU.

To read the original press release, please click here.


BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.